GET THE APP

ADAMTS1 is a candidate for a unique tool for detecting hypoxic en | 745
Journal of Clinical & Experimental Dermatology Research

Journal of Clinical & Experimental Dermatology Research
Open Access

ISSN: 2155-9554

+44 1478 350008

ADAMTS1 is a candidate for a unique tool for detecting hypoxic endothelial cells


International Conference & Exhibition on Clinical Research Dermatology, Ophthalmology & Cardiology

5-6 July 2011 San Francisco, USA

Mehmet Zeynel Cilek

Scientific Tracks Abstracts: JCEDR

Abstract :

ADAMTS1 (a disintegrin and metalloproteinase with thrombospondin motifs 1) is a member of the matrix metalloproteinase family. We have previously reported that ADAMTS1 was strongly expressed in myocardial infarction and it is a hypoxic early response gene expressed by endothelial cells in a timedependent manner. In this study, we investigated whether ADAMTS1 promoter-driven reporter signal is detectable by acute hypoxia in vivo and in vitro. We constructed the GFP (green fluorescent protein) expression vector (ADAMTS1-GFP) driven by ADAMTS1 promoter and compared it with the constitutive GFP-expressing vector driven by cytomegalovirus (CMV) promoter (CMV-GFP). We delivered ADAMTS1-GFP or CMV-GFP by electroporation and examined whether GFP signals can be detected under the hypoxia. When we cultured ADAMTS1-GFP-transfected human umbilical vein cells (HUVEC) under normoxia, there were few GFP signals, while CMV-GFP-transfected HUVEC showed considerable GFP signals. When HUVEC was stimulated with hypoxia, GFP signals were induced by ADAMTS1-GFP. Interestingly, the GFP signals reached its peak at 3 h under hypoxia stimulation. In vivo experiments, ischemic hind limb model were produced and ADAMTS1- GFP drove GFP signals in the ischemic hind limb. In summary, we have demonstrated that the ADAMTS1promoter induced the reporter gene expression by hypoxia, and its induction is transient. This is the first reportshowing the unique acute hypoxia-activated gene expression system.

Biography :

Mehmet Zeynel CILEK has completed his Ph.D at Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sci ences, Department of Molecular Biology and Biochemistry in December 2010; He is now a post-doctoral research associate at the Okayama University. He has published 5 papers in reputed journals.Reference: 1- Mehmet Zeynel Cilek , Satoshi Hirohata, Omer Faruk Hatipoglu, Hiroko Ogawa, Toru Miyoshi,JunkoInagaki, Takashi Ohtsuki, Hiroshi Harada, Shigeshi Kamikawa, Shozo Kusachi, Yoshifumi Ninomiya, AHR, anovel acute hypoxia- response sequence, drives reporter gene under hypoxia in vitro and in vivo, Cell Biology International, (2011) 35, 1?8 2- Omer F. Hatipoglu, Satoshi Hirohata, M. Zeynel Cilek , Kadir Demircan, Hiroko Ogawa, Toru Miyoshi, Masanari Obika, Ryoko Shinohata, Shozo Kusachi, Yoshifumi Ninomiya, ADAMTS1 Is A Unique Hypoxic Early Response Gene Expressed By Endothelial Cells, Journal of Biological Chemistry,2009, Jun 12;28 4(24):16325- 33. 3- Keigo Nakamura, Satoshi Hirohata, Takahashi Murakami, Toru Miyoshi, Kadir Demircan, ToshikataOohashi,Hiroko Ogawa, Kazuy a Koten, Kenichi Toeda, Shozo Kusachi, Yoshifumi Ninomiya and Yasushi Shiratori,Dynamic induction of ADAMTS1 gene in the early phase of acute myocardial infarction. J Biochem (Tokyo)2004; 136:439?46.

Top
https://www.olimpbase.org/1937/